3.2 Glucose Homeostasis: Hypoglycemia & Hyperglycemia

Glucose Homeostasis in the Neonate

At birth, the umbilical cord is clamped, abruptly terminating the continuous maternal transfer of glucose. The neonate must immediately transition to independent glucose homeostasis. This transition is mediated by a surge in catecholamines and glucagon, which stimulates glycogenolysis (breakdown of glycogen stores) and gluconeogenesis (synthesis of glucose from non-carbohydrate sources).

In healthy term infants, blood glucose levels fall to a physiological nadir during the first 1 to 2 hours of life, typically stabilizing between 50 and 60 mg/dL before rising to normal baseline levels (>70 mg/dL) by 72 hours of life. However, infants with limited glycogen stores or dysregulated endocrine systems are at high risk for failing this transition.

---

Neonatal Hypoglycemia

Definition & Thresholds

For the RNC-NIC exam, neonatal hypoglycemia is generally defined as a blood glucose level <40 mg/dL during the first 24 hours of life, and <50 mg/dL thereafter. Clinical practice guidelines target maintaining blood glucose levels above 45 mg/dL prior to feeds in asymptomatic high-risk infants on the first day of life. Any blood glucose level <40 mg/dL requires immediate intervention.

Risk Factors

• Decreased Glycogen Stores (Inadequate Supply):
  • Prematurity: Glycogen is deposited primarily during the third trimester.
  • Intrauterine Growth Restriction (IUGR) / Small for Gestational Age (SGA): Placental insufficiency impairs glycogen deposition.
• Increased Glucose Utilization (High Demand):
  • Perinatal Asphyxia / Hypoxia: Anaerobic metabolism consumes glucose at a rate 18 times faster than aerobic metabolism.
  • Sepsis & Cold Stress: Increased metabolic rate and thermogenesis (brown fat metabolism) rapidly deplete glucose stores.
• Hyperinsulinism (Excessive Insulin Production):
  • Infants of Diabetic Mothers (IDM): Maternal hyperglycemia leads to fetal hyperglycemia, stimulating fetal pancreatic beta-cell hyperplasia. After birth, the maternal glucose supply ceases, but hyperinsulinism persists, driving glucose into cells.
  • Large for Gestational Age (LGA): Often associated with unrecognized maternal gestational diabetes.
  • Beckwith-Wiedemann Syndrome: Genetic disorder characterized by macrosomia, macroglossia, and pancreatic hyperplasia.

Clinical Manifestations

Clinical signs of hypoglycemia are non-specific and result from neurogenic (autonomic) activation and neuroglycopenia (brain glucose deprivation):

• Neurogenic Signs: Jitteriness, tremors, tachycardia, diaphoresis, and tachypnea.
• Neuroglycopenic Signs: Hypotonia, lethargy, poor feeding, weak or high-pitched cry, hypothermia, apnea, and seizures.
• Note: Many high-risk neonates exhibit no clinical symptoms, emphasizing the necessity of routine screening for at-risk populations.

Clinical Management

Management is dictated by the presence of symptoms and the depth of hypoglycemia.

Step 1: Immediate Bolus (For Symptomatic or Severe Hypoglycemia)

• Therapy: Administer a bolus of Dextrose 10% in Water (D10W) at 2 mL/kg (equivalent to 200 mg/kg dextrose) IV over 5 to 10 minutes.
• Exam Trap: Never use hypertonic dextrose solutions (e.g., D20W, D25W, or D50W) for boluses. These hypertonic fluids cause severe endothelial irritation (phlebitis) and trigger a rapid, massive insulin surge, causing severe rebound hypoglycemia.

Step 2: Continuous Glucose Infusion

Follow the D10W bolus immediately with a continuous IV infusion of D10W at a Glucose Infusion Rate (GIR) of 6 to 8 mg/kg/min.

Step 3: GIR Calculations

Calculating the GIR is a core RNC-NIC competency. Two main formulas are used depending on the available clinical data:

Method A: Using Hourly IV Rate

$\text{GIR (mg/kg/min)} = \frac{\text{IV Rate (mL/hour)} \times \text{Dextrose Concentration (\%)}}{6 \times \text{Weight (kg)}}$

• Clinical Scenario: A 3 kg infant is receiving D10W at a rate of 18 mL/hour. Calculate the GIR. $\text{GIR} = \frac{18 \times 10}{6 \times 3} = \frac{180}{18} = 10 \text{ mg/kg/min}$

Method B: Using Daily Fluid Volume (mL/kg/day)

$\text{GIR (mg/kg/min)} = \frac{\text{Fluid Rate (mL/kg/day)} \times \text{Dextrose Concentration (\%)}}{144}$

• Clinical Scenario: A 2 kg infant is receiving D12.5W at 120 mL/kg/day. Calculate the GIR. $\text{GIR} = \frac{120 \times 12.5}{144} = \frac{1500}{144} = 10.42 \text{ mg/kg/min}$

Step 4: Escalation & Refractory Hypoglycemia

If blood glucose remains <40 mg/dL, increase the GIR by 1 to 2 mg/kg/min increments.

• Concentration Limits: The maximum dextrose concentration for a peripheral IV line is 12.5% to prevent chemical sclerosis. Higher concentrations (e.g., D15W, D20W) require a central venous catheter (umbilical venous catheter [UVC] or percutaneously inserted central catheter [PICC]).
• Pharmacotherapy for Refractory Hypoglycemia:
  • Hydrocortisone: 5 mg/kg/day IV divided every 12 hours. It decreases peripheral glucose utilization and enhances gluconeogenesis.
  • Glucagon: 0.1 to 0.2 mg/kg IM or IV as a bolus, or 5 to 10 mcg/kg/hour continuous infusion. It mobilizes hepatic glycogen stores. (Ineffective in SGA/preterm infants who lack glycogen stores).
  • Diazoxide: 5 to 15 mg/kg/day orally. Used for congenital hyperinsulinism; inhibits insulin release from beta cells.

Step 5: Weaning IV Glucose

Once blood glucose remains stable (typically >50-60 mg/dL) for 12 to 24 hours and enteral feedings are well tolerated:

• Wean the GIR gradually by 1 to 2 mg/kg/min every few hours.
• Exam Trap: Never abruptly discontinue IV dextrose or rapidly decrease fluid rates. Abrupt withdrawal causes sudden hypoglycemic rebound due to persistent endogenous insulin production.

---

Neonatal Hyperglycemia

Definition & Risk Factors

Neonatal hyperglycemia is defined as a blood glucose level >125 to 150 mg/dL. It is most common in extremely low birth weight (ELBW) infants (<1000g) due to insulin resistance, immature pancreatic response, and continued hepatic glucose production despite high circulating glucose.

• Risk Factors: Excessive dextrose administration (high GIR), sepsis (stress-induced cortisol and epinephrine release inhibit insulin secretion), methylxanthine therapy (caffeine or theophylline), and corticosteroid therapy (dexamethasone).

Clinical Complications

• Osmotic Diuresis: When blood glucose exceeds the renal threshold (typically 150 to 180 mg/dL), glucose spills into the urine (glucosuria). This drags water with it, causing polyuria, dehydration, and electrolyte depletion.
• Intraventricular Hemorrhage (IVH): Rapid rises in blood glucose increase serum osmolality. This draws water out of brain cells, causing cellular dehydration and fluctuating cerebral blood flow, increasing the risk of IVH.

Clinical Management

1. Reduce GIR: Decrease the dextrose concentration or fluid rate. Do not lower the GIR below 4 to 5 mg/kg/min, as this is the minimum glucose requirement for basic cerebral metabolic function.
2. Treat Underlying Sepsis: Obtain cultures and initiate antibiotics if indicated.
3. Insulin Infusion: If glucose remains >200-250 mg/dL despite reducing the GIR:
   • Initiate continuous IV insulin (regular insulin) at 0.01 to 0.1 units/kg/hour.
   • Nurses' Role: Monitor blood glucose hourly during titration. Insulin binds to IV tubing plastic; flush the line with the insulin solution (at least 10-20 mL) before connecting to the patient to saturate binding sites.